Settle down guys - here are the facts !! ........
Prima has done 5 phase I studys on CVac until they found what worked. Then they completed a phase II study and are doing a second phase IIb for a ?Potency Assay? and to comply with US FDA IND. The phase III will provide ?statistical significance for US FDA and EU EMA approval?
On Abagovomab see this news
http://www.medpagetoday.com/MeetingCoverage/ASCO/26956
For Abagovomab mode of delivery(CA-125 monoclonal antibody) mimicked the previously failed phase III study of Oregovomab in 2009
See article on Oregovomab
http://jco.ascopubs.org/content/27/3/418.full
Notice the author is Dr Jonathan Berek on why Oregovomab failed. The expert call from Dr Berek on why CVac is a winner
Listen to this opinion on
http://www.investorcalendar.com/IC/CEPage.asp?ID=163542
abagovomab vs oregovomab - facts ...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.015(4.41%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.0¢ | 34.0¢ | $1.270M | 3.611M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 286261 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 253490 | 7 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |